Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Eden LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 11.50p 11.00p 12.00p 11.50p 11.50p 11.50p 53,527 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.9 -0.8 -0.3 - 23.83

Eden Share Discussion Threads

Showing 6101 to 6124 of 6125 messages
Chat Pages: 245  244  243  242  241  240  239  238  237  236  235  234  Older
DateSubjectAuthorDiscuss
16/1/2019
21:54
Agree with the future revenue build. The trick nevertheless always being, to get it over the line to profits.
brucie5
16/1/2019
21:54
There may need to be some chunky milestones/licensing fees this year, to forestall jak's cash all. I certainly expect there to be. What sorts of deal on Sustaine are you expecting, beyond a further equity stake?
brucie5
16/1/2019
21:11
EPA is affected by Trump's government shutdown, I believe.
brucie5
16/1/2019
18:05
Indeed with the Biopesticide market growing and set to treble between 2017 and 2024 the numbers by 2020/1/2 should be mouth watering. By then TT and Bayer and maybe the Redwings will all have Agnews Gold medal for Tactical Ambiguity.
supersonico
16/1/2019
17:28
Super, It is a terrific distribution addition for the future, but we know it will take a couple of years of regulatory approval, then sales and then adoption will take another 1-2 years based on performance to-date. I thought that US EPA approval would be speedier than the EU. Pam Marrone also indicated the same when on a panel with SS saying how long the EU takes and thankfully they do not have that issue in the US. Nonetheless, the US still appears to be taking a while. I think all shareholders need to know and what to know, where is the value today, even those who choose to stay invested for many more years to come. Why, because for years expectation has been high(ish) and still it is yet to happen. So understanding true vale today (11p, 20p, 50p) will be key to understanding future potential growth for this company and within a global regulatory framework. Should Eden get a big win on Sustaine with Sipcam, Sumitomo et al, then I think Eden might be ripe for an approach from ANO. I don't think we can be very far away in time now from hearing that story and assessing our investment future in Eden.
investingisatrickygame
16/1/2019
15:42
OK - thanks for that. Maybe something regarding Sustaine will be announced before the 7 February 2019 - Proactive Investors One2One Investor Forum.
weyweyumfozo
16/1/2019
15:24
wey, hxxp://www.edenresearch.com/~/media/Files/E/Eden-Research/documents/reports-and-presentation/agm-presentation-2018.pdf Slide 12 at the bottom, including Comprehensive evaluation of Eden products and technologies ●Up-front investment includes a fee of €0.6m ●Further fee paid upon execution of option with further exercise fees due before 1/19 Option exercised and £800k paid Further exercise fees due before 1/19. We have not been advised on any. I assume these exercise fees are related to Sustaine encapsulation and co-encapsulation. If the distribution territories had to be settled before 1/19 then I assume the tech does too. Nothing is written to say otherwise so it doesn't seem an unreasonable assumption to me.
investingisatrickygame
16/1/2019
15:06
Investing..., You say: "And also Sustaine evaluation by Sipcam which in the June 2017 RNS and on an Eden presentation the implied date for commentary was the 31/12 2018." I can't see an implication for commentary on 31/12 2018 in the June 2017 RNS, nor in the current Presentation on the Eden website. Could you quote me the wording of what you refer to, or provide a link please?
weyweyumfozo
16/1/2019
14:44
Wan and wey, I could not agree more and wan, I'm surprised to see you say 'investors are due a detailed explanation for the change in timeline and commentary'. It is unusual of you to pass such comment, but it is spot on. The same applies to Bayer 1) Timeline, sales in H2 2018, now unclear) 2) 4 products to be launched, now 3 3) 2 products seemingly good to go, but not launched & I assume because of reformulation on product 3, but do not know 4) How long is the anticipated reformulation of product 3 Bayer has been in the pipeline since 2013 And also Sustaine evaluation by Sipcam which in the June 2017 RNS and on an Eden presentation the implied date for commentary was the 31/12 2018. All we have thus far is ongoing. How long is ongoing? I think to be fair that though Eden has apparent significant potential, that investors are due a detailed explanation on many aspects of the business. Not just a trading update that told us little, not just a snappy Proactive interview, but a deeper more expansive explanation of Eden. Supersonico is right that Eden is delay after delay and if you look at Eden's powerpoint presentations on their website over the years, there are a lot of slides that are simply repeated, therefore static. Value needs to be delivered into the share price now, you cannot be all about the potential year after year. A detailed explanation will better help investors understand and help Eden to build the share price.
investingisatrickygame
16/1/2019
14:12
wan, I just find it annoying to be less well informed now (the stated launch date) about the head-lice product than we were four months ago. Hopefully someone will get more information out of them on the 7 February 2019 - Proactive Investors One2One Investor Forum.
weyweyumfozo
16/1/2019
13:24
Weywey...On the face of it, most people probably wouldn't disagree with your verdict! However, clearly something has changed, it's just that we don't know the details, or indeed the outcome yet (hence it was taboo subject during yesterday's interview?). Thus, one way or another, I am expecting some form of change. Without any notable/strategic change, investors are due a detailed explanation for the change in timeline and commentary (which any change may possibly address?).
wan
16/1/2019
12:23
24 September 2018 Half Year Report: "Production of the head-lice product will begin before the end of 2018 with product launch in the United Kingdom ("U.K.") in January coinciding with the back-to-school schedule.".. ..."Eden plans to supply a concentrate of encapsulated active ingredients (based upon Eden's microencapsulation technology) to TerpeneTech who will then formulate the finished product, which will initially be sold by its distribution partner into the discount-retail market in the U.K." 10 October 2018 Regulatory Clearance RNS: "Sales of the head-lice product into the distribution channel are expected to begin before the end of 2018 in the UK, where TerpeneTech's distribution channel partner has already been established, with commercial launch at the beginning of 2019.".... ..."Eden will supply a concentrate of encapsulated active ingredients (based upon Eden's microencapsulation technology) to TerpeneTech, who will then formulate the finished product for initial sale by its distribution partner into the UK retail market." 15 January 2019 Trading Update: "On 10 October 2018, the Company announced that TerpeneTech, Eden's associate company, had received regulatory clearance to sell its head-lice product in the European Economic Area. TerpeneTech is now working with its distribution partner to launch that product in the U.K. in 2019." ================================================================================ How on earth do you go from "product launch in the United Kingdom ("U.K.") in January coinciding with the back-to-school schedule" to "launch that product in the U.K. in 2019"? This is saying that it could be up to another 11 months instead of now! Have they even supplied a concentrate of encapsulated active ingredients to TT? Pathetic.
weyweyumfozo
16/1/2019
12:07
Very Very Very rough guide of scale of growing market opportunity based purely on the unscientific Wikipedia production numbers. hTTps://en.wikipedia.org/wiki/List_of_countries_by_grape_production Grape production Tons. Current. Italy/Spain/France/Greece/Portugal/Cyprus/Albania/Bulgaria = 22,583,320 Recent Sipcam etal additions: China/ USA / Brazil / Mexico / Argentina / Chili / Japan / South Africa/ New Zealand / Australia= 31,797,911
supersonico
16/1/2019
10:01
Direction of 'unstoppable' Travel News: Vine and wine become organic. hTTps://www.bioecoactual.com/ca/2019/01/14/vinya-i-vi-fan-ecologics/ The University of La Rioja hosted the ninth edition of the University Wine Conference of the Ecological Wine, a meeting that shows that organic wine production is not only getting a fast and deserved recognition on the part of consumers but also consolidated its scientific basis. The inaugural session of the day included a lecture by Ana María Díez-Navajas, a researcher at the Basque Institute for Research and Technological Development NEIKER-Tecnalia, about the current reality and the future challenges of sustainable viticulture. The statistics indicate that the present in the sector is hopeful. In the whole of Spain, according to data from the Ministry of Agriculture, Fisheries and Food, in 2017, the area covered in organic farming occupied by vineyards was 106,897 hectares, with a growth of 3.1% compared to The 2016 data. The ministerial yearbook indicates that in Spain there were 939 wineries and wine bottlers recognized as organic farming activities in Spain in 2017. For autonomous communities, Castilla-La Mancha headed the ranking last year with 56,697 hectares of organic production vineyards, followed by Catalonia (14,880 hectares) and Murcia (12,249). To get an idea of ​​the growth of the sector, we can remember that in 2003, the first year of official data, all 16,453 hectares of vineyard cultivation with organic farming methods were registered in Spain as a whole. The most outstanding example of the rapid growth of the organic grape sector is found in Catalonia. In 2000, vineyards that implemented organic farming occupied only 455 hectares (249 in the province of Barcelona, ​​29 in Girona, 52 in Lleida and 125 in Tarragona), according to the official statistics of the Consell Català of Ecological Agricultural Production (CCPAE). After a rapid and steady growth, in the year 2017, the extension of organic vineyard reached 14,880 hectares in Catalonia (7,919 in the province of Barcelona, ​​330 in Girona, 938 in Lleida and 5,693 in Tarragona). In fact, in Catalonia, the growth of the organic grape sector is the fastest and most constant of all types of organic crops for human consumption; only surpassed in the set of the ecological production by the growth of the crops of the sector of meadows, pastures and forrajes. The new European standards have the advantage of offering greater transparency and facilitating recognition by consumers. Unification of the regulations, final push. Often criticism in the European Union and all its administrative, political and legal framework with the argument of the bureaucratization. In the case of organic production, it must be admitted that the EU is making efforts not to fall back on progress that seems unstoppable. In the positive section we can emphasize, for example, that the agreement reached in 2012 by the EU on the standards to be applied in the wine sector has been an important boost that has served to unify criteria, improve quality controls and facilitate the promotion of products with the use of a common denomination and labeling. The European regulation was approved by the Standing Committee on Organic Agriculture (SCOF) and allowed the official use of the expression "organic wine" in the labels of products that meet the established requirements. In fact, until 2012 the European Union only recognized expressions such as "wine made with organic grapes", but did not have a common regulation on vinification processes, that is, all the steps from grapes to wine . The new European standards have the advantage of offering greater transparency and facilitating recognition by consumers. In addition, it has allowed to strengthen the international position of organic wines of the EU, since many other wine-producing countries (United States, Chile, Australia or South Africa) had already set standards for organic wines. The Regulation in force since 2012 establishes a subset of oenological practices and substances (vinification) for the production of organic wines. For example, organic wines are not authorized nor sodium acid nor desulphurisation, and the level of sulfites in organic wine must be between 30-50 mg per liter, below their conventional equivalents (depending on the content in residual sugar) Of course, in addition to these vinification practices, the "organic wine" must naturally be produced from organic grapes; according to the norms established in the regulation approved by the EU in 2007. The website Wines of Spain explains in a divulging way some of the characteristics that can be found in organic wines. Thus, it indicates this specialized portal, "the first difference between a wine that is ecological and one common is the amount of polyphenols that contains the grape with which it is made in question. And it is that the wines we are referring to have an amount of polyphenols much higher than the others. " "Another difference with respect to the wines that we all know today is the way in which the pests that can attack the strains are prevented. In the ecological, no chemical product is used at any time. In this way, pesticides will never affect the taste of the wine or its benefits, "said the page in an article full of praise for organic production.
supersonico
16/1/2019
08:44
I agree and the new Territories announced have some big producers within their ranks so adding nicely to the opportunities to grow Mevelone sales substantially imo. On Sustaine yes will be good to be further informed by Sipcam and Collaborators. From looking back at the choreography of Sipcam events announced by Eden the One below I believe along with yesterdays statement tell us that a positive announcement on Sustaine will be forth coming. 'Sean Smith, Chief Executive Officer of Eden, said: "We are pleased that Sipcam wishes to expand the footprint it has to sell Mevalone in a number of additional territories which shows the confidence and belief that Sipcam has in 3logy and Eden's Sustaine technology'. (Sipcam_exercises_Option_for_distribution)
supersonico
16/1/2019
07:52
As I alluded to yesterday, we have to ask what TerpeneTech, a tiny company (with a website that looks like it was written on a sheet of A4!) can achieve? It was odd that TerpeneTech did not even get so much as a mention in the interview with Sean Smith yesterday......a taboo subject I guess! In post 166 I highlighted the following - Hedrin is the UK's top selling head lice brand, in its time on the market (around 12 years I believe) Hedrin has sold well over 40 million packs in 30 countries (source; Independent Community Pharmacists). In 2013 STADA bought Thornton and Ross (one of their leading brands is Hedrin) for £221m. On January 12, 2018, Stada reached an agreement with Sanofi on the early termination of the license agreement for its Hedrin products in Belgium, Spain, and Portugal. Sanofi had acquired these from the STADA subsidiary Thornton & Ross. Another transaction, for Vamousse, also caught my attention, but first a bit of history. TyraTech was a small AIM Company (since bought out by American Vanguard Corp acquiring all TyraTech shares it did not already own). TyraTech developed and owned the Vamousse head-lice brand, it was a very small company in market cap terms, but nonetheless they managed to make significant inroads into the head-lice market, as highlighted below - 9th May 2017 TyraTech Inc. (AIM: TYR, and TYRU), a life sciences company focused on nature-derived insect and parasite control products, today announces its results for the year ended 31 December 2016. Operational highlights • Vamousse® sales in US grew by 10% to $5.9 million over 2015 and gained 3% points of market share • Vamousse sales in UK grew by 27% to £1.3 million in local currency (2015: £1 million) and gained market share over competition • Vamousse distribution network increased in the US - driven by the addition of Rite Aid, the third largest pharmacy chain in the US with more than 4,500 stores • Addition of 450 Morrisons stores, the fourth largest chain of supermarkets in the UK • Vamousse Head Lice Treatment was voted in the UK Pharmacy Product of the Year 2017 - Best Advertising Campaign by Independent Pharmacy (END) Then in December 2017 TyraTech sold the head-lice Vamousse brand for USD17.5 million to Alliance Pharma PLC. So, it can be done, but what is the best strategy now that large players own the leading brands and can it be executed effectively by TerpeneTech? I cannot see TerpeneTech achieving what TyraTech did in market penetration terms, at least not in their present form. Hence they are looking at a distribution partner, but have they got the necessary management/negotiating expertise? Given the delays associated with the animal health products, one would assume not! So, I am expecting some form of change! Eden is the ultimate owner of the IP and has a 29.9% stake in TerpeneTech. Food for thought at least and time will tell
wan
16/1/2019
07:48
Super They've pretty much got the world's grape production covered. I'm far more interested in futuure RNS's expanding upon Sipcam's evaluation of Sustaine and what that means. Equally, future RNS's on other parties and Sustaine. Are we about to move into vertical sector and geographical agreements in specific regards to our "game-changing" tech?
investingisatrickygame
16/1/2019
06:27
Sean Smith Proactive on 15/1/2019; "we also very much expect to see an expansion, further expansion of the relationships that we have covering new territories and in particular some additional significant grape producing territories globally" We only have Sipcam/Sumitomo for Grapes so that's what the relationship SS is referring to imo and begs the question of when will Eden announce formally and Publicly the wider Sumitomo relationship as it becomes more evident that those 'additional territories' are not covered by Sipcam? hTTps://en.wikipedia.org/wiki/List_of_countries_by_grape_production hTTps://www.sumitomocorp.com/en/jp/about/point hTTp://www.sipcam-oxon.com/public/companies/#asia India ? Turkey ?
supersonico
15/1/2019
21:16
jr, good man/woman. I will be delighted to award you first prize, should you get there this Christmas, and personally send you a magnum of my favourite Portuguese red, Bons Ventos, if I can find one. Out of interest, how long have you been in this one?
brucie5
15/1/2019
20:51
Still 36p thanks Brucie. This is AIM after all. Onwards and upwards. As frustrating as it seems I am willing to keep the faith a couple more years longer. Been here long enough now so may as well stay for a while longer.
jr_
15/1/2019
19:38
AttyG, No need to be a sleuth..it's in the RNS'S Chile / South Africa via Valent Bioscience/ Sumitomo Sipcam agreements, investment and proposed placing 2017; "The significant resource and knowledge that Sipcam has at its disposal, as well as the substantial investment they are making in the commercialisation of Eden's products and technology, will also serve us well in developing and, ultimately, distributing Eden's products and technologies in countries in which Sipcam has a presence and will also allow Eden to leverage those capabilities in countries where they do not." ……………. hTTps://www.proactive investors.co.uk/companies/news/212623/shore-capital-sees-number-of-potentially-exciting-product-applications-for-eden-research-pending-authorisations-212623.html join the proactive to the investors Nice field of Hemp pictured :) The clues are every where
supersonico
15/1/2019
18:37
hTTps://www.wsj.com/articles/bayer-ag-faces-new-setback-for-roundup-weedkiller-in-france-11547571839
supersonico
15/1/2019
18:00
SK, sales up 58%, with potential catalysts of: further take up in existing territories; new territories coming on line; broadening applications; and then Cedroz. All against a highly favourable macro environment on use of biocides vs. chemicals. Never mind: Sustaine encapsulation; CAP and consumer verticals - all, I would have thought, coming online in 2019. Sales may be small, but Mevalone only started selling to any significance in 2017. Draw yourself a little graph to see what happens to 1.6m when it increases by: 60%; 100%; 150%.... Then consider: Strategic investor on board (SIPCAM), who has recently taken its options. Licensing with majors (BAYER, SIMITOMO, EASTMAN). Hmm. How come they don't seem to share your pessimism? Do you know more than they do? Well, I'm excited, but, hey, this is 3 year investment. So clearly not for you?
brucie5
15/1/2019
17:54
The Global Biopesticide Market is expected to get increased from USD 3.36 Billion in 2017 to USD 8.82 Billion with CAGR of 17.4% from 2017. hTTps://twitter.com/Vegalab_Inc/status/1085177547518889987
supersonico
Chat Pages: 245  244  243  242  241  240  239  238  237  236  235  234  Older
Your Recent History
LSE
EDEN
Eden
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190116 22:46:33